5AM Ventures VI L.P. 13D and 13G filings for Enliven Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-29 6:12 pm Sale |
2024-07-25 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 2,304,332 4.900% |
-531,543 (-18.74%) |
Filing |
| 2024-04-15 7:21 pm Sale |
2024-04-11 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 2,835,875 6.100% |
-1,000,100 (-26.07%) |
Filing |
| 2024-02-16 4:15 pm Sale |
2024-02-14 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 3,835,975 9.300% |
-825,000 (-17.70%) |
Filing |
| 2024-02-02 4:15 pm Sale |
2024-01-31 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 4,660,975 11.300% |
-700,563 (-13.07%) |
Filing |
| 2023-08-28 4:15 pm Sale |
2023-08-24 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 5,361,538 13.000% |
-436,937 (-7.54%) |
Filing |
| 2023-03-06 4:00 pm Purchase |
2023-02-23 | 13D | Enliven Therapeutics, Inc. ELVN |
5AM Ventures VI L.P. | 5,798,475 14.100% |
5,798,475 (New Position) |
Filing |